Innoviva Inc

Healthcare · Biotechnology

20.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 120 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INVA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	33	44	40	59	49	70	52	67	62	80	55	64	66	76	79	79	89	90	86	101	98	108	90	108	67	66	76	81	67	86	77	103	90	92	89	100	108	118	98	120	443
Cost of Revenue	0.3	0.3	0.4	0.3	0.3	6.0	5.8	4.4	1.5	0.0	–	–	–	–	–	0.6	1.0	0.2	0.0	0.0	0.4	3.5	3.5	3.6	15	13	23	24	10	13	11	18	10.0	7.2	8.8	11	26	42	22	29	119
Gross Profit	33	43	40	58	48	70	52	67	62	80	55	64	66	76	79	79	89	90	86	101	98	108	90	108	52	53	53	57	57	73	67	85	80	85	80	90	82	76	76	91	324
Research & Development	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.0	–	–	–	–	–	0.6	1.0	0.2	0.0	0.0	0.4	0.0	5.8	14	12	10.0	13	15	4.0	2.4	3.9	2.6	3.6	3.7	4.4	8.0	14	4.6	5.2	5.2	29
Selling, General & Administrative	5.1	5.6	11	10	8.3	2.8	12	4.4	4.0	2.6	3.0	4.3	5.0	2.3	2.6	2.6	3.3	5.5	6.0	4.2	2.9	3.1	6.5	12	239	18	20	24	29	26	30	28	26	31	27	26	27	32	32	35	126
Total Operating Expenses	5.4	5.6	11	11	8.6	3.1	12	4.4	4.0	2.6	3.0	4.3	5.0	2.3	2.6	3.2	4.3	5.7	6.0	4.3	3.3	3.2	12	26	40	22	32	39	33	35	41	30	30	42	121	138	47	37	38	40	162
Operating Income	28	38	29	48	40	66	41	63	58	77	52	60	61	74	76	76	84	85	79	97	95	105	78	83	12	31	21	18	24	38	26	55	50	43	-41	-49	35	39	38	51	163
Interest Expense	13	13	13	12	10	8.4	7.7	6.5	5.2	4.6	4.6	4.7	4.7	4.7	4.5	4.6	4.6	4.7	4.7	4.7	4.8	4.8	3.0	3.7	5.1	4.0	4.4	4.4	4.4	6.0	5.9	5.8	5.8	4.7	4.7	4.7	4.0	3.3	5.4	5.5	18
Pre-Tax Income	15	25	17	35	24	59	30	57	50	73	49	56	58	70	95	118	50	91	129	136	123	56	45	20	286	-65	41	5.8	86	61	45	-39	6.8	25	-39	73	98	195	235	-108	419
Income Tax Expense	13	12	12	13	16	8.0	11	8.0	11	-196	8.5	10	11	12	16	20	8.9	16	20	25	21	11	6.9	-0.9	57	3.6	6.3	4.5	3.9	-0.3	8.6	-4.6	5.6	4.4	8.0	8.9	7.9	31	48	-25	62
Net Income	15	25	17	35	24	58	30	55	47	264	34	38	40	46	65	77	28	54	94	89	72	10	16	0.9	266	-68	35	1.3	82	62	37	-35	1.2	20	-47	64	90	164	187	-83	357
EBITDA	32	42	33	51	38	70	41	65	56	76	50	56	58	67	89	105	45	78	122	122	101	26	29	7.3	24	41	34	34	24	74	57	-24	19	36	-27	84	108	208	239	267	823

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings